Clinical Trial Update: Evaluation of Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2 for 26 Weeks [NA]

View source ↗

Summary

Clinical trial evaluating biological and functional changes in healthy smokers after switching to THS 2.2 for 26 weeks; completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking-related Conditions

Drugs mentioned

• THS 2.2 (tobacco heated product variant)

Snippet

Sponsor: Philip Morris Products S.A. | Conditions: Smoking | NA | Status: COMPLETED | Results posted: 2019-08-21